Explore <strong>Isoflurane</strong>, a potent inhalational anesthetic used for general anesthesia. Learn about its uses, proper dosage, potential side effects, and how it safely induces and maintains unconsciousness during surgery.
Browse our catalog for available pharmaceutical products and competitive pricing.
Isoflurane is a potent, non-flammable, halogenated ether used as an inhalational anesthetic for the induction and maintenance of general anesthesia. It belongs to a class of volatile liquid anesthetics, characterized by its rapid onset and recovery, making it a cornerstone in modern surgical practice. Administered via a specialized vaporizer, Isoflurane produces a state of unconsciousness, muscle relaxation, and analgesia, allowing for complex surgical procedures to be performed safely and effectively. Its precise control over anesthetic depth is a key advantage, enabling anesthesiologists to titrate the dose according to patient needs and surgical demands.
The development of Isoflurane marked a significant advancement in anesthetic pharmacology. First synthesized in 1965 by Ross Terrell, it was introduced into clinical practice in 1979. Its introduction followed earlier halogenated ethers like Halothane and Enflurane, offering an improved safety profile, particularly regarding cardiac stability and reduced metabolism, which contributed to its widespread adoption. Isoflurane quickly became a preferred choice for many surgical settings due to its favorable pharmacokinetic and pharmacodynamic properties, demonstrating a lower incidence of arrhythmias and less hepatic metabolism compared to its predecessors, thereby minimizing the risk of liver toxicity.
As a halogenated ether, Isoflurane is classified as a general anesthetic agent. Its chemical structure, 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether, contributes to its unique properties. It is a clear, colorless liquid with a pungent, ethereal odor. The Anatomic Therapeutic Chemical (ATC) classification system assigns Isoflurane the code N01AE06, falling under the broader category N01 (Anesthetics), N01A (General Anesthetics), and N01AE (Halogenated Hydrocarbons). This classification highlights its role as a central nervous system depressant, capable of inducing and maintaining a reversible state of unconsciousness, essential for patient comfort and safety during surgery.
The precise molecular mechanism of action for Isoflurane, like other general anesthetics, is complex and not fully elucidated, but it is understood to involve multiple targets within the central nervous system (CNS). Isoflurane primarily acts by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABAA receptors. By binding to specific sites on these ligand-gated ion channels, Isoflurane increases the frequency and duration of chloride ion channel opening, leading to an influx of chloride ions into neurons. This hyperpolarizes the neuronal membrane, making it more difficult for neurons to fire action potentials, thereby reducing neuronal excitability and leading to CNS depression, which manifests as anesthesia.
Beyond its significant interaction with GABAA receptors, Isoflurane also modulates other ion channels and receptors contributing to its anesthetic effects. It inhibits excitatory neurotransmitter systems, such as N-methyl-D-aspartate (NMDA) receptors, which are involved in learning and memory. Furthermore, Isoflurane activates certain potassium channels, including two-pore domain potassium channels (K2P channels), which contributes to neuronal hyperpolarization and reduced excitability. It also appears to affect neuronal nicotinic acetylcholine receptors and glycine receptors. The cumulative effect of these diverse interactions leads to the profound CNS depression required for general anesthesia, encompassing amnesia, immobility, analgesia, and unconsciousness.
Isoflurane is predominantly used as an inhalational agent for the induction and maintenance of general anesthesia in a wide range of surgical procedures. Its ability to provide a stable plane of anesthesia, coupled with its relatively rapid onset and recovery profile, makes it a valuable tool for anesthesiologists. The depth of anesthesia can be precisely controlled by adjusting the concentration of Isoflurane administered, allowing for titration to individual patient needs and the requirements of the surgical intervention.
Isoflurane is administered via inhalation using a calibrated vaporizer that delivers a precise concentration of the volatile liquid mixed with oxygen, air, or nitrous oxide. The dosage is typically expressed as a percentage of inspired gas and is adjusted based on the patient's age, weight, physical status, and the desired depth of anesthesia, guided by clinical signs and monitoring parameters such as Minimum Alveolar Concentration (MAC). MAC represents the alveolar concentration of an anesthetic at which 50% of patients will not move in response to a surgical incision. The MAC for Isoflurane is approximately 1.15% in a 40-year-old adult, but it decreases with increasing age and in the presence of other sedatives or opioids.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Induction of Anesthesia | 0.5-3% (gradually increased) | Continuous until induction | Inhalation |
| Maintenance of Anesthesia (Adults) | 1-2.5% (with N2O) or 1.5-3.5% (with O2/air) | Continuous during procedure | Inhalation |
| Maintenance of Anesthesia (Pediatrics) | 1.5-3% (with N2O) or 2-4% (with O2/air) | Continuous during procedure | Inhalation |
| High-Risk/Elderly Patients | 0.5-1.5% (lower MAC requirements) | Continuous during procedure | Inhalation |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition.
While Isoflurane is generally well-tolerated, like all anesthetic agents, it can cause a range of side effects. These can vary in severity and incidence depending on the individual patient, the dose administered, and the duration of exposure. Anesthesiologists carefully monitor patients for these effects throughout the anesthetic period and in the immediate post-operative phase.
Isoflurane can interact with various medications, potentially altering its anesthetic effects or increasing the risk of adverse reactions. It is crucial for the anesthesiologist to be aware of all medications a patient is taking prior to administration of Isoflurane to mitigate potential risks and adjust anesthetic management accordingly.
The use of Isoflurane is contraindicated in certain patient populations and conditions due to the potential for serious adverse outcomes. Careful patient assessment and a thorough medical history are essential before administering this anesthetic.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.
Isoflurane is an anesthetic administered for the duration of a surgical or medical procedure, which typically lasts from minutes to several hours. It is not intended nor safe for chronic or long-term use outside of an acute, controlled medical setting. Prolonged exposure carries risks of cumulative side effects and is not medically indicated for any condition requiring continuous, extended administration.
No, Isoflurane is an inhalational anesthetic administered in a medical setting, typically to patients who have been fasting prior to surgery to reduce the risk of aspiration. It is not a medication that is 'taken with food' in the conventional sense. Its administration requires specialized equipment and monitoring by trained medical professionals.
Isoflurane is administered by an anesthesiologist or certified nurse anesthetist as part of a carefully planned medical procedure. It is not a medication that a patient self-administers or can 'miss a dose' of. Its dosage is continuously adjusted by the medical team during the procedure to maintain the desired depth of anesthesia.
Isoflurane is a potent prescription-only medication and a controlled substance in many regions, used exclusively in licensed medical facilities such as hospitals and surgical centers. It cannot be purchased by individuals from pharmacies or online retailers without a valid medical license and proper authorization. Any attempt to buy Isoflurane outside of legitimate medical channels is illegal and extremely dangerous, as its administration requires expert medical supervision and specialized equipment to ensure patient safety.